KNOXVILLE, Tenn., Jan. 21 /PRNewswire-FirstCall/ -- CTI Molecular Imaging, Inc. , announced today that it will release its earnings results for the fiscal first quarter ended December 31, 2004, before the market opens on Tuesday, February 1, 2005.
The company will host a conference call on that date to discuss these results at 9:00 am EST. The dial-in number for the earnings call is (706) 643-3432. A replay of the call will be available for one week until February 8. The replay number is (800) 642-1687 and the reservation number is 3583738.
A simultaneous webcast of the call will be accessible via the Internet at http://www.ctimi.com/ in the investor relations section. A replay of the webcast will also be archived on this site.
About CTI Molecular Imaging:
CTI Molecular Imaging, Inc. is a leading supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, neurological disorders and cardiac disease. Additional information is available at: http://www.ctimi.com/ .
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding CTI Molecular Imaging, Inc.'s business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Further information regarding such risks and uncertainties and other factors that could adversely affect CTI or cause actual results to differ materially from those anticipated in forward- looking statements are included in CTI's Annual Report on Form 10-K for the fiscal year ended September 30, 2004 and in other reports CTI files with the SEC. CTI undertakes no obligation to update or revise any forward-looking statements.
CTI Molecular Imaging, Inc.
CONTACT: David Gill of CTI Molecular Imaging, Inc., +1-865-218-2000